Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.

Héquet D, Kralidis G, Carrel T, Cusini A, Garzoni C, Hullin R, Meylan PR, Mohacsi P, Mueller NJ, Ruschitzka F, Tozzi P, van Delden C, Weisser M, Wilhelm MJ, Pascual M, Manuel O; Swiss Transplant Cohort Study (STCS).

BMC Infect Dis. 2016 Jul 8;16:321. doi: 10.1186/s12879-016-1658-0.

2.

Reply to Cunha et al.

Wójtowicz A, Lecompte TD, Bibert S, Manuel O, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Khanna N, Mueller NJ, Meylan PR, Pascual M, van Delden C, Bochud PY; Swiss Transplant Cohort Study.

Clin Infect Dis. 2015 Dec 15;61(12):1894-5. doi: 10.1093/cid/civ681. Epub 2015 Aug 10. No abstract available.

3.

PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant.

Wójtowicz A, Lecompte TD, Bibert S, Manuel O, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch H, Khanna N, Mueller NJ, Meylan PR, Pascual M, van Delden C, Bochud PY; Swiss Transplant Cohort Study.

Clin Infect Dis. 2015 Aug 15;61(4):619-22. doi: 10.1093/cid/civ386. Epub 2015 May 14.

4.

IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.

Wójtowicz A, Gresnigt MS, Lecompte T, Bibert S, Manuel O, Joosten LA, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch HH, Weisser M, Mueller NJ, Meylan PR, Steiger J, Kutalik Z, Pascual M, van Delden C, van de Veerdonk FL, Bochud PY; Swiss Transplant Cohort Study (STCS); Swiss Transplant Cohort Study STCS.

J Infect Dis. 2015 May 15;211(10):1646-57. doi: 10.1093/infdis/jiu636. Epub 2014 Nov 14.

5.

Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study.

Bucheli E, Kralidis G, Boggian K, Cusini A, Garzoni C, Manuel O, Meylan PR, Mueller NJ, Khanna N, van Delden C, Berger C, Koller MT, Weisser M; Swiss Transplant Cohort Study.

Transpl Infect Dis. 2014 Feb;16(1):26-36. doi: 10.1111/tid.12168. Epub 2013 Dec 16.

PMID:
24330137
6.

Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.

Manuel O, Kralidis G, Mueller NJ, Hirsch HH, Garzoni C, van Delden C, Berger C, Boggian K, Cusini A, Koller MT, Weisser M, Pascual M, Meylan PR; Swiss Transplant Cohort Study.

Am J Transplant. 2013 Sep;13(9):2402-10. doi: 10.1111/ajt.12388. Epub 2013 Aug 5.

7.

Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study.

Kucera P, Gerber S, Marques-Vidal P, Meylan PR.

Eur J Obstet Gynecol Reprod Biol. 2012 Jan;160(1):13-7. doi: 10.1016/j.ejogrb.2011.09.030. Epub 2011 Oct 7.

PMID:
21982938
8.

Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.

Manuel O, Humar A, Berutto C, Ely L, Giulieri S, Lien D, Meylan PR, Weinkauf J, Pascual M, Nador R, Aubert JD, Kumar D.

J Heart Lung Transplant. 2011 Jun;30(6):679-84. doi: 10.1016/j.healun.2011.01.705. Epub 2011 Mar 5.

PMID:
21377898
9.

Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.

Boillat Blanco N, Pascual M, Venetz JP, Nseir G, Meylan PR, Manuel O.

Transplantation. 2011 Jan 27;91(2):251-5. doi: 10.1097/TP.0b013e318200b9f0.

PMID:
21099744
10.

Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.

Manuel O, Pascual M, Perrottet N, Lamoth F, Venetz JP, Decosterd LA, Buclin T, Meylan PR.

Clin Transplant. 2010 Nov-Dec;24(6):794-800. doi: 10.1111/j.1399-0012.2009.01205.x.

PMID:
20105200
11.

[Management of infection after organ transplantation by the primary care physician].

Manuel O, Meylan PR, van Delden C.

Rev Med Suisse. 2009 Apr 1;5(197):722-6. French.

PMID:
19492515
12.

Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation.

Wasserfallen JB, Kast-Brückner M, Manuel O, Venetz JP, Meylan PR, Pascual M.

Int J Technol Assess Health Care. 2008 Summer;24(3):312-7. doi: 10.1017/S0266462308080410.

PMID:
18601799
13.

Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.

Manuel O, Venetz JP, Fellay J, Wasserfallen JB, Sturzenegger N, Fontana M, Matter M, Meylan PR, Pascual M.

Swiss Med Wkly. 2007 Dec 1;137(47-48):669-76.

PMID:
18058275
14.

Real-time PCR for type-specific identification of herpes simplex in clinical samples: evaluation of type-specific results in the context of CNS diseases.

Meylan S, Robert D, Estrade C, Grimbuehler V, Péter O, Meylan PR, Sahli R.

J Clin Virol. 2008 Feb;41(2):87-91. Epub 2007 Nov 26.

PMID:
18037340
15.

Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiency.

Manuel O, Tarr PE, Venetz JP, Trendelenburg M, Meylan PR, Pascual M.

Transpl Infect Dis. 2007 Sep;9(3):214-8.

PMID:
17692067
16.

Late-onset cytomegalovirus disease in patients with solid organ transplant.

Meylan PR, Manuel O.

Curr Opin Infect Dis. 2007 Aug;20(4):412-8. Review.

PMID:
17609602
17.

Influenza transmission to recipient through lung transplantation.

Meylan PR, Aubert JD, Kaiser L.

Transpl Infect Dis. 2007 Mar;9(1):55-7.

PMID:
17313474
18.

Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation.

Manuel O, Pascual M, Trendelenburg M, Meylan PR.

Transplantation. 2007 Feb 15;83(3):359-62.

PMID:
17297414
19.

Oral valganciclovir for cytomegalovirus colitis after liver transplantation.

Manuel O, Meylan PR, Rotman S, Fontana M, Moradpour D, Pascual M.

Transplantation. 2007 Jan 27;83(2):239-40. No abstract available.

PMID:
17264825
20.

Mycobacterium tuberculosis subverts innate immunity to evade specific effectors.

Loeuillet C, Martinon F, Perez C, Munoz M, Thome M, Meylan PR.

J Immunol. 2006 Nov 1;177(9):6245-55.

21.

Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.

Meylan PR, Pascual M.

Clin Infect Dis. 2006 Oct 1;43(7):881-3. Epub 2006 Aug 23. No abstract available.

PMID:
16941369
22.

Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.

Fellay J, Venetz JP, Pascual M, Aubert JD, Seudoux C, Meylan PR.

Am J Transplant. 2005 Jul;5(7):1781-2; author reply 1783. No abstract available.

23.
24.

Cytomegalovirus load in bronchoalveolar lavage fluid: a clue to the diagnosis of cytomegalovirus pneumonia?

Meylan PR, Zanetti G.

J Infect Dis. 2005 Jun 15;191(12):2153, author reply 2153-4. No abstract available.

PMID:
15898004
25.

Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.

Fellay J, Venetz JP, Aubert JD, Seydoux C, Pascual M, Meylan PR.

Transplant Proc. 2005 Mar;37(2):949-51.

PMID:
15848585
26.

High dosage of oral valaciclovir as an alternative treatment of varicella zoster acute retinal necrosis syndrome.

Guex-Crosier Y, Meylan PR.

Eye (Lond). 2006 Feb;20(2):247. No abstract available.

PMID:
15776013
27.

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

Harari A, Vallelian F, Meylan PR, Pantaleo G.

J Immunol. 2005 Jan 15;174(2):1037-45.

28.

Interactions of processed Nef (58-206) with virion proteins of HIV type 1.

Ciuffi A, Munoz M, Bleiber G, Favre M, Stutz F, Telenti A, Meylan PR.

AIDS Res Hum Retroviruses. 2004 Apr;20(4):399-407.

PMID:
15157358
29.
30.

Determinants of protracted cytomegalovirus infection in solid-organ transplant patients.

Muheim C, Vogel G, Seydoux C, Gillet M, Mosimann F, Von Segesser L, Sahli R, Estrade C, van Melle G, Meylan PR.

Transplantation. 2002 Jul 27;74(2):226-36.

PMID:
12151736
31.

HIV-1-infected patients with focal neurologic signs: diagnostic role of PCR for Toxoplasma gondii, Epstein-Barr virus, and JC virus.

Hirsch HH, Meylan PR, Zimmerli W, Iten A, Battegay M, Erb P; Swiss HIV Cohort Study .

Clin Microbiol Infect. 1998;4(10):577-584.

32.

An adenovirus-based fluorescent reporter vector to identify and isolate HIV-infected cells.

Richman L, Meylan PR, Munoz M, Pinaud S, Mirkovitch J.

J Virol Methods. 2002 Jan;99(1-2):9-21.

PMID:
11684299
33.

Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity.

Künzle N, Petignat C, Francioli P, Vogel G, Seydoux C, Corpataux JM, Sahli R, Meylan PR.

Transpl Infect Dis. 2000 Sep;2(3):118-26.

PMID:
11429022
34.

Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.

Costello E, Munoz M, Buetti E, Meylan PR, Diggelmann H, Thali M.

Gene Ther. 2000 Apr;7(7):596-604.

35.
36.

CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.

Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD.

AIDS. 2000 Jan 28;14(2):173-80.

PMID:
10708288
37.

Detection of CMV DNA in peripheral blood leukocytes as a long-range harbinger of CMV disease in HIV-infected patients. Swiss HIV Cohort Study.

Jaton KR, Muheim CR, Barbani MT, Sahli RR, Rudaz PR, Meylan PR.

Ocul Immunol Inflamm. 1999 Dec;7(3-4):147-57.

PMID:
10611722
38.

Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients. Swiss HIV Cohort Study.

Bart PA, Meuwly JY, Corpataux JM, Yerly S, Rizzardi P, Fleury S, Munoz M, Knabenhans C, Welbon C, Pantaleo G, Meylan PR.

AIDS. 1999 Aug 20;13(12):1503-9.

PMID:
10465074
39.

Role of CD40 ligand in Mycobacterium avium infection.

Hayashi T, Rao SP, Meylan PR, Kornbluth RS, Catanzaro A.

Infect Immun. 1999 Jul;67(7):3558-65.

40.

Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system.

Iten A, Chatelard P, Vuadens P, Miklossy J, Meuli R, Sahli R, Meylan PR.

J Neurovirol. 1999 Apr;5(2):172-80.

PMID:
10321981
41.

Monitoring the response of AIDS-related progressive multifocal leukoencephalopathy to HAART and cidofovir by PCR for JC virus DNA in the CSF.

Meylan PR, Vuadens P, Maeder P, Sahli R, Tagan MC.

Eur Neurol. 1999;41(3):172-4. No abstract available.

PMID:
10202253
42.

The nef gene controls syncytium formation in primary human lymphocytes and macrophages infected by HIV type 1.

Meylan PR, Baumgartner M, Ciuffi A, Munoz M, Sahli R.

AIDS Res Hum Retroviruses. 1998 Nov 20;14(17):1531-42.

PMID:
9840286
43.

Single tube competitive PCR for quantitation of CMV DNA in the blood of HIV+ and solid organ transplant patients.

Chatellard P, Sahli R, Iten A, von Overbeck J, Meylan PR.

J Virol Methods. 1998 Apr;71(2):137-46.

PMID:
9626947
44.

Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis.

Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, Meylan PR.

J Immunol. 1998 Jun 1;160(11):5448-54.

45.

Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration.

Bürgisser P, Spertini F, Weyrich-Suter C, Pagani JL, Meylan PR.

J Infect Dis. 1997 May;175(5):1202-5.

PMID:
9129086
46.

Potential role of dideoxyinosine and hydroxyurea combination in prophylaxis of HIV infection after accidental percutaneous exposure.

Raharinivo B, Meylan PR.

AIDS Res Hum Retroviruses. 1997 Mar 20;13(5):367-9. No abstract available.

PMID:
9075476
47.

Viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients.

Meylan PR, Bürgisser P, Weyrich-Suter C, Spertini F.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Sep;13(1):39-47.

PMID:
8797685
48.

Risk of transmission of human immunodeficiency virus infection during tympano-ossicular homograft: an experimental study.

Meylan PR, Duscher A, Mudry A, Monnier P.

Laryngoscope. 1996 Mar;106(3 Pt 1):334-7.

PMID:
8614199
49.

Myelitis due to varicella-zoster virus in an immunocompromised patient without a cutaneous rash.

Meylan PR, Miklossy J, Iten A, Petignat C, Meuli R, Zufferey J, Sahli R.

Clin Infect Dis. 1995 Jan;20(1):206-8. No abstract available.

PMID:
7727664
50.

Supplemental Content

Loading ...
Support Center